Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Vaxart ( (VXRT) ) is now available.
Vaxart, Inc. had planned a special meeting of stockholders on September 5, 2025, which was adjourned to September 19, 2025, to allow more time for voting on a proposal. However, on September 18, 2025, the company decided to withdraw the proposal and will not reconvene the meeting, indicating a shift in their strategic decisions.
The most recent analyst rating on (VXRT) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Vaxart stock, see the VXRT Stock Forecast page.
Spark’s Take on VXRT Stock
According to Spark, TipRanks’ AI Analyst, VXRT is a Neutral.
Vaxart’s stock score reflects strong revenue growth and promising vaccine developments, but is weighed down by profitability challenges, negative valuation metrics, and operational uncertainties.
To see Spark’s full report on VXRT stock, click here.
More about Vaxart
Vaxart, Inc. operates in the biotechnology industry, focusing on the development of oral vaccines for various infectious diseases.
Average Trading Volume: 1,878,368
Technical Sentiment Signal: Sell
Current Market Cap: $88.82M
Learn more about VXRT stock on TipRanks’ Stock Analysis page.